These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8842793)

  • 1. Torsade de pointes occurring early during oral amiodarone treatment.
    Faggiano P; Gardini A; D'Aloia A; Benedini G; Giordano A
    Int J Cardiol; 1996 Jul; 55(2):205-8. PubMed ID: 8842793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.
    Badshah A; Mirza B; Janjua M; Nair R; Steinman RT; Cotant JF
    Hellenic J Cardiol; 2009; 50(3):224-6. PubMed ID: 19465366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes induced by short-term oral amiodarone therapy.
    Lim HE; Pak HN; Ahn JC; Song WH; Kim YH
    Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
    Silvetti MS; Drago F; Bevilacqua M; Ragonese P
    Ital Heart J; 2001 Mar; 2(3):231-6. PubMed ID: 11305536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy.
    Yamada S; Kuga K; Yamaguchi I
    Jpn Circ J; 2001 Mar; 65(3):236-8. PubMed ID: 11266201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
    Schlienger RG; Haefeli WE; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY.
    Lakušić N; Slivnjak V; Ciglenečki N; Cerovec D
    Acta Clin Croat; 2019 Dec; 58(4):751-756. PubMed ID: 32665746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early proarrhythmia during intravenous amiodarone treatment.
    Tomcsányi J; Merkely B; Tenczer J; Papp L; Karlócai K
    Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):968-70. PubMed ID: 10392400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
    van Opstal JM; Schoenmakers M; Verduyn SC; de Groot SH; Leunissen JD; van Der Hulst FF; Molenschot MM; Wellens HJ; Vos MA
    Circulation; 2001 Nov; 104(22):2722-7. PubMed ID: 11723026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.
    Hohnloser SH; Klingenheben T; Singh BN
    Ann Intern Med; 1994 Oct; 121(7):529-35. PubMed ID: 8067651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital monitoring of T-wave alternans in a case of amiodarone-induced torsade de pointes: clinical and methodologic insights.
    Kawaguchi T; Takasugi N; Kubota T; Takasugi M; Kanamori H; Ushikoshi H; Hattori A; Aoyama T; Kawasaki M; Nishigaki K; Takemura G; Minatoguchi S; Verrier RL
    Europace; 2012 Sep; 14(9):1372-4. PubMed ID: 22389418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone-induced torsade de pointes during bladder irrigation: an unusual presentation--a case report.
    Voigt L; Coromilas J; Saul BI; Kassotis J
    Angiology; 2003; 54(2):229-31. PubMed ID: 12678199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amiodarone-induced torsade de pointes--five case reports].
    Kukla P; Słowiak-Lewińska T
    Kardiol Pol; 2004 Apr; 60(4):365-70; discussion 371. PubMed ID: 15226788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced torsade de pointes.
    Trohman RG; Sahu J
    Circulation; 1999 Apr; 99(16):E7. PubMed ID: 10217665
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of drug-induced torsades de pointes with intravenous amiodarone.
    Shenthar J; Rachaiah JM; Pillai V; Chakali SS; Balasubramanian V; Chollenhalli Nanjappa M
    Indian Heart J; 2017; 69(6):707-713. PubMed ID: 29174246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Torsade de pointes secondary to amiodarone overdose].
    Lee Hwang D; Barriales Alvarez V; Lasa Larraya G; Rondán Murillo J
    Med Clin (Barc); 2004 Jun; 123(4):156-7. PubMed ID: 15274812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.